benzoyl peroxide has been researched along with clindamycin in 166 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (7.23) | 18.7374 |
| 1990's | 4 (2.41) | 18.2507 |
| 2000's | 76 (45.78) | 29.6817 |
| 2010's | 64 (38.55) | 24.3611 |
| 2020's | 10 (6.02) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Frank, SB | 1 |
| Binnick, S; Langer, R | 1 |
| Foglia, AN; Fried, F; Harkaway, KS; Lee, WL; Leyden, JJ; McGinley, KJ; Shalita, AR | 1 |
| Rajka, G | 1 |
| Auld, J | 1 |
| Fanta, D; Neumann, R; Raab, W; Schmidt, JB | 1 |
| Pochi, PE; Rothman, KF | 1 |
| Baker, MD; Mills, OH; Swinyer, LJ; Swinyer, TA | 1 |
| Popovich, NG; Sperandio, GJ | 1 |
| Schachner, L | 1 |
| Cochran, R; Flannigan, SA; Tausend, R; Tucker, SB | 1 |
| Kligman, AM; Leyden, JJ; McGinley, K; Mills, OH | 1 |
| Rich, M | 1 |
| Brown, RH; Dunlap, FE; Kraus, SJ; Packman, AM; Webster, GF | 1 |
| Caron, D; Clucas, A; Sorba, V; Verschoore, M | 1 |
| Chalker, DK; Huerter, CJ; Katz, HI; Kempers, SE; Klauda, HC; Lindholm, JS; Lookingbill, DP; Schelling, DJ; Swinehart, JM | 1 |
| Ellis, CN; Goldfarb, MT; Hickman, J; Jones, TM; Katz, HI; Leyden, J; Tschen, E | 1 |
| Levy, S; Leyden, J | 1 |
| Tschen, E | 1 |
| Leyden, J | 1 |
| Levy, S | 1 |
| Connolly, MA; Jones, TM; Katz, HI; Kraus, SJ; Levy, SF; Monroe, EW; Tschen, EH | 1 |
| Berger, RS; Connolly, MA; Dunlap, FE; Ellis, CN; Levy, SF; Leyden, JJ | 1 |
| Kaidbey, K; Levy, SF; Leyden, J | 1 |
| Plosker, GL; Warner, GT | 1 |
| Leyden, JJ | 3 |
| Draelos, ZD; Tanghetti, EA | 1 |
| Bojar, R; Cunliffe, WJ; Holland, KT; Levy, SF | 1 |
| Tan, JK | 1 |
| Gans, EH; Kligman, AM | 1 |
| Davis, M; Shavin, J; Weiss, JW | 1 |
| Davis, MW; Shavin, J; Weiss, J | 2 |
| Davis, MW; Rist, T | 1 |
| Davis, MW; Fernandez-Obregon, A | 1 |
| Davis, MW; Rodriguez, D | 1 |
| Shavin, J; Weiss, J | 1 |
| Jones, T; Tschen, E | 1 |
| Fagundes, DS; Fraser, JM; Klauda, HC | 1 |
| Bamford, JT | 1 |
| Abeck, D | 1 |
| Breneman, D; Levy, S; Leyden, J; Savin, R; Vamvakias, G; VandePol, C | 1 |
| Leyden, JJ; Shalita, A; Thiboutot, D | 1 |
| Barba, A; Cook-Bolden, FE; Halder, R; Taylor, S | 1 |
| Shalita, AR; Taylor, GA | 1 |
| Shalita, A | 1 |
| Purdy, S | 2 |
| Gollnick, HP; Graupe, K; Zaumseil, RP | 1 |
| Finlay, AY; Kellett, N; West, F | 1 |
| Del Rosso, JQ; Tanghetti, E | 1 |
| Abramovits, W; Loven, K; Shalita, A; Solomon, B; Tanghetti, E | 1 |
| Huddleston, K; Nighland, M; Nyirady, J; Wisniewski, S; Yusuf, M | 1 |
| Bos, JD; Kingswijk, MM; Menke, HE; Reitsma, JB; Relyveld, GN; Westerhof, W | 1 |
| Malik, MA; Mott, T; Rao, S; Wilder, L | 1 |
| Langner, A; Layton, A; Sheehan-Dare, R | 1 |
| Del Rosso, JQ | 5 |
| Kligman, AM; Stoudemayer, M; Vamvakias, G; Zhen, Y | 1 |
| Tanghetti, E | 2 |
| Kircik, L | 2 |
| Taylor, SC | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Ambroziak, M; Chu, A; Goulden, V; Langner, A | 1 |
| Keating, GM; McKeage, K | 1 |
| Burkhart, CG; Burkhart, CN | 1 |
| Castro, GA; Ferreira, LA | 1 |
| Bhambri, S; Del Rosso, JQ; Jitpraphai, W; Momin, S | 1 |
| Dhawan, S; Kircik, L; Tanghetti, E; Wilson, D | 1 |
| Dosik, JS; Vamvakias, G | 1 |
| Calvarese, B; Chen, D; Thiboutot, D; Webster, G; Weiss, J; Zaenglein, A | 1 |
| Callender, V; Dhawan, SS; Draelos, ZD; Young, C | 1 |
| Jensen, B; Jin, M; Laubscher, T; Regier, L | 1 |
| Kim, MB; Ko, HC; Kwon, KS; Oh, CK; Seo, SH; Song, M | 1 |
| Deberker, D; Purdy, S | 1 |
| Dhawan, SS | 1 |
| Kircik, LH | 2 |
| Angel, A; Bucks, D; Del Rosso, J; Sarpotdar, P; Yu, K | 1 |
| Calvarese, B; Chen, D; Gold, MH; Mraz, S; Rich, P; Webster, G | 1 |
| Lerche, CM; Philipsen, PA; Poulsen, T; Wulf, HC | 1 |
| Del Rosso, JQ; Eichenfield, L; Parr, L; Shalita, A; Swinyer, L; Tanghetti, E; Thiboutot, D; Tschen, E | 1 |
| Dhawan, S; Green, L; Kircik, L; Parr, L; Tanghetti, E; Thiboutot, D; Wilson, D | 1 |
| Biswas, S; Dutta, RN; Mondal, KK; Sarkar, DK | 1 |
| Alió, AB; Barnard, J; Fischer, TC; Wohlrab, J; Zouboulis, CC | 1 |
| Dunn, SP; Kemp, K; Vlahovic, TC | 1 |
| Eichenfield, L | 2 |
| Almekinder, JL; Fu, JJ; Jackson, JM | 1 |
| Karsai, S; Raulin, C; Schmitt, L | 1 |
| Degitz, K; Fluhr, JW | 1 |
| Kimball, AB; Seidler, EM | 2 |
| Botella-Estrada, R; Echeverría, B; Escutia, B; Guillén, C | 1 |
| Chen, DM; Merikle, E; Thiboutot, DM; Webster, G | 1 |
| Alió Saenz, AB; Draelos, ZD; Potts, A | 1 |
| Kim, YC; Lee, DJ; Lee, JS; Sim, JH | 1 |
| Belinchón, I; Betlloch, I; Montero, LC; Toledo, F | 1 |
| Chen, DM; Feldman, SR | 1 |
| Akarsu, S; Fetil, E; Gül, E; Güneş, AT; Yücel, F | 1 |
| Alió Sáenz, AB; Eichenfield, LF | 1 |
| Borelli, C; Burgdorf, W; Mehra, T; Röcken, M; Schaller, M | 1 |
| Zeichner, JA | 1 |
| Cook-Bolden, FE | 1 |
| Callender, VD | 1 |
| Guerra-Tapia, A | 1 |
| Haddican, M; Patel, RV; Wong, V; Zeichner, JA | 1 |
| Eichenfield, LF; Krakowski, AC | 1 |
| Draelos, ZD; Oresajo, C; Raab, S; Shalita, AR; Thiboutot, D; Yatskayer, M | 1 |
| Ting, W | 1 |
| Cirigliano, M; Gonzalez, P; Vila, R | 1 |
| Ehst, BD; Goreshi, R; Samrao, A | 1 |
| Harper, JC | 2 |
| Dhawan, SS; Gwazdauskas, J | 1 |
| Baumann, LS; Dahl, A; Figueras, K; Oresajo, C; Yatskayer, M | 1 |
| Haddican, M; Linkner, RV; Wong, V; Zeichner, JA | 1 |
| Gold, LS | 1 |
| Del Rosso, J; Dover, JS; Draelos, Z; Gold, M; Lin, X; Shamban, A; Stein, L; Swinyer, L; Thiboutot, D; Webster, G; Zaenglein, AL | 1 |
| Grove, G; Gwazdauskas, J; Zerweck, C | 1 |
| Gounari, P; Kougias, M; Sioula, E; Skourtis, A; Vallianou, N | 1 |
| Bettoli, V; Montis, A; Ruina, G; Virgili, A; Zauli, S | 1 |
| Alió Sáenz, AB; Hashimoto, H; Kawashima, M; Ono, M; Yamada, M | 1 |
| Cook-Bolden, FE; Korotzer, A; Pariser, DM; Rich, P | 1 |
| DI Meo, N; Errichetti, E; Patrone, P; Piccirillo, F; Stinco, G; Trevisan, G; Valent, F | 1 |
| Hawryluk, EB; LeBoeuf, NR; Litsas, G; Sheu, J; Thakuria, M | 1 |
| Altavilla, G; Borgia, F; Cannavò, SP; Guarneri, F; Pollicino, A; Vaccaro, M | 2 |
| Stein Gold, L | 1 |
| Blume-Peytavi, U; Dobos, G; Hillmann, K; Kottner, J; Richter, C; Stroux, A; Trojahn, C | 1 |
| Hennig, M; Ress, C; Schaller, M; Sebastian, M; Seidel, D | 1 |
| Dong, XQ; Fang, H; Gu, H; Gu, J; Hamedani, AG; Hao, F; He, YL; Huang, JH; Li, FQ; Li, J; Li, M; Lu, QJ; Luo, D; Sheng, WX; Sun, QN; Tian, HQ; Tu, YT; Wang, G; Wu, Y; Xi, LY; Xu, JH; Yang, HL; Zhao, G; Zheng, J; Zheng, M | 1 |
| Hasegawa, S; Hashimoto, H; Ino, H; Nakahara, N; Saenz, AA; Takahashi, N; Wakamatsu, A | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Austin, BA; Fleischer, AB | 1 |
| Kawada, A; Kurokawa, I; Oiso, N | 1 |
| Blume-Peytavi, U; Canfield, D; Kottner, J; Patwardhan, SV; Richter, C; Vogt, A | 1 |
| Dizay, HH; Lau, DG; Nottage, WM | 1 |
| Baldwin, HE; Lin, T; Stein Gold, L | 1 |
| Baldwin, H; Gold, MH; Lin, T | 1 |
| Dall'Oglio, F; Lacarrubba, F; Micali, G; Tedeschi, A | 1 |
| Bhatia, N; Hoffman, LK; Kircik, LH; Zeichner, J | 1 |
| Endo, A; Hatanaka, T; Hayashi, N; Kawashima, M; Kurokawa, I; Siakpere, O; Yamada, M | 1 |
| Chalermchai, T; Jurairattanaporn, N; Ophaswongse, S; Udompataikul, M | 1 |
| Amar, L; Kircik, LH | 1 |
| Heckmann, N; Heidari, KS; Jalali, O; Omid, R; Rick Hatch, GF; She, R; Vangsness, CT; Weber, AE | 1 |
| Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H | 1 |
| Crawford, R; Cutbush, K; Ezure, Y; Foster, AL; Paterson, DL; Schuetz, MA | 1 |
| Baldwin, H; Beer, K; Bhatt, V; Callender, V; Draelos, Z; Gold, M; Kircik, LH; Lain, E; Pariser, DM; Pillai, R; Sadick, N; Stein Gold, L; Tanghetti, EA; Weiss, JS | 1 |
| Lake, E; Nickles, MA | 1 |
| Doma, K; Grant, A; Hinton, D; Morse, L; Symonds, T; Wilkinson, M | 1 |
| Ebell, MH | 1 |
| Taylor, SA | 1 |
| Chen, P; Chen, Y; Han, W; Li, L; Li, S; Nie, Y; Sun, J | 1 |
| Aarts, P; Ardon, CB; Prens, EP; Reeves, JL; van der Zee, HH | 1 |
38 review(s) available for benzoyl peroxide and clindamycin
| Article | Year |
|---|---|
Topical therapy of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Dicarboxylic Acids; Erythromycin; Humans; Miconazole; Oxytetracycline; Salicylates; Salicylic Acid; Tretinoin | 1986 |
Use of oral and topical agents for acne in pregnancy.
Topics: Abnormalities, Drug-Induced; Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Benzoyl Peroxide; Clindamycin; Erythromycin; Female; Humans; Pregnancy; Pregnancy Complications; Salicylates; Tetracyclines; Tretinoin | 1988 |
The treatment of acne: a contemporary review.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Capsules; Child; Clindamycin; Erythromycin; Gels; Humans; Isotretinoin; Tretinoin; Zinc | 1983 |
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Randomized Controlled Trials as Topic | 2002 |
Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Humans; Patient Satisfaction; Severity of Illness Index | 2003 |
Study design and selection criteria in the BEST study.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Protocols; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Patient Selection; Severity of Illness Index | 2003 |
Overall results of the BEST study following treatment of patients with mild to moderate acne.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Satisfaction; Severity of Illness Index | 2003 |
The BEST study: evaluating efficacy by selected demographic subsets.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Demography; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Racial Groups; Severity of Illness Index; Sex Factors; Skin Pigmentation | 2003 |
The BEST study: results according to prior treatment.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Erythromycin; Female; Humans; Male; Middle Aged; Patient Satisfaction; Retinoids; Retreatment; Severity of Illness Index; Treatment Outcome | 2003 |
Implications of the BEST study.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index | 2003 |
A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Humans; Severity of Illness Index | 2002 |
[Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Humans; Keratolytic Agents; Propionibacterium acnes; Time Factors; Tretinoin | 2003 |
Antibiotic resistance in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Resistance, Bacterial; Humans; Propionibacterium acnes | 2004 |
Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Erythromycin; Humans | 2004 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Drug Therapy, Combination; Erythromycin; Humans; Isotretinoin; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2005 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythromycin; Humans; Isotretinoin; Minocycline; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2006 |
Clinical inquiries. What is the best treatment for mild to moderate acne?
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Humans; Retinoids | 2006 |
The impact and importance of resistance.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Propionibacterium acnes; Retinoids; Time Factors | 2007 |
Utilizing combination therapy for ethnic skin.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Asian People; Benzoyl Peroxide; Black or African American; Clindamycin; Dermatologic Agents; Dimethylpolysiloxanes; Drug Combinations; Drug Therapy, Combination; Glycerol; Hispanic or Latino; Humans; Hyperpigmentation; Keratolytic Agents; Naphthalenes; Randomized Controlled Trials as Topic; Skin Pigmentation; Tretinoin | 2007 |
Combination topical therapy in the treatment of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Retinoids | 2006 |
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Patient Satisfaction; Quality of Life | 2008 |
Novel vesicular and particulate drug delivery systems for topical treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Delivery Systems; Drug Stability; Humans; Imidazoles; Liposomes; Microspheres; Nanoparticles; Nitriles; Tretinoin | 2008 |
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatitis, Irritant; Dermatologic Agents; Drug Combinations; Drug Interactions; Drug Stability; Gels; Humans; Pharmaceutical Vehicles; Skin Absorption; Tretinoin | 2008 |
Acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Isotretinoin | 2008 |
[Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Pregnancy; Randomized Controlled Trials as Topic; Tetracyclines | 2010 |
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Combinations; Humans; Salicylic Acid | 2010 |
Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Inflammation; Randomized Controlled Trials as Topic | 2011 |
Optimizing topical combination therapy for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Humans; Propionibacterium acnes; Retinoids | 2012 |
Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel?
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Benzoyl Peroxide; Cicatrix; Clindamycin; Drug Combinations; Female; Gels; Humans; Hyperpigmentation; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Onexton gel for acne.
Topics: Acne Vulgaris; Administration, Topical; Animals; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Randomized Controlled Trials as Topic | 2015 |
When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Chronic Disease; Clindamycin; Clinical Trials as Topic; Dermatologic Agents; Humans; Patient Compliance; Treatment Outcome | 2016 |
Management of Severe Acne Vulgaris With Topical Therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Humans; Severity of Illness Index | 2017 |
Management of comedonal acne vulgaris with fixed-combination topical therapy.
Topics: Acne Vulgaris; Adapalene, Benzoyl Peroxide Drug Combination; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dapsone; Drug Combinations; Drug Therapy, Combination; Gels; Humans; Retinoids | 2018 |
Topical Vehicle Formulations in the Treatment of Acne.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Compounding; Exanthema; Humans; Retinoids; Treatment Outcome; Tretinoin | 2018 |
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Erythromycin; Female; Glycolates; Humans; Keratolytic Agents; Male; Mandelic Acids; Niacinamide; Patient Dropouts; Pyruvic Acid; Quality of Life; Salicylic Acid; Sulfur; Tretinoin; Young Adult; Zinc | 2020 |
Cutibacterium acnes in shoulder surgery: a scoping review of strategies for prevention, diagnosis, and treatment.
Topics: Benzoyl Peroxide; Clindamycin; Gram-Positive Bacterial Infections; Humans; Propionibacterium acnes; Shoulder; Shoulder Joint | 2021 |
Topical dapsone in the treatment of acne: a systematic review.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Dapsone; Doxycycline; Humans; Isotretinoin; Retinoids | 2022 |
For Mild to Moderate Acne, Adapalene Plus Benzoyl Peroxide, Clindamycin Plus Benzoyl Peroxide, and Adapalene Alone Are Most Effective.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
81 trial(s) available for benzoyl peroxide and clindamycin
| Article | Year |
|---|---|
Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Coagulase; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Staphylococcus; Staphylococcus epidermidis; Tetracycline | 1992 |
[1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Peroxides | 1984 |
Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
Topics: Acne Vulgaris; Administration, Topical; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Keratolytic Agents; Middle Aged; Treatment Outcome | 1996 |
Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments.
Topics: Adapalene; Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Erythromycin; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Naphthalenes; Skin | 1997 |
Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Erythromycin; Evaluation Studies as Topic; Female; Follow-Up Studies; Gels; Humans; Irritants; Keratolytic Agents; Logistic Models; Male; Pharmaceutical Vehicles; Placebos; Remission Induction; Safety | 1997 |
A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Pharmaceutical Vehicles; Statistics, Nonparametric | 2001 |
Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Pharmaceutical Vehicles; Severity of Illness Index; Treatment Outcome | 2001 |
Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Colony Count, Microbial; Drug Combinations; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Propionibacterium acnes; Time Factors | 2002 |
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; California; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; North Carolina; Severity of Illness Index; Treatment Outcome | 2002 |
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Colony Count, Microbial; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Propionibacterium acnes; Treatment Outcome | 2002 |
Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
Topics: Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Female; Humans; Propionibacterium acnes; Skin | 2002 |
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Surveys and Questionnaires | 2002 |
New therapy update--A unique combination formulation in the treatment of inflammatory acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Patient Satisfaction; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Administration Schedule; Female; Gels; History, 17th Century; Humans; Male; Prospective Studies; Rosacea; Severity of Illness Index; Treatment Outcome; United States | 2004 |
Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; New York; Pennsylvania; Rosacea; Severity of Illness Index; Treatment Outcome | 2004 |
Twice-daily applications of benzoyl peroxide 5%/clindamycin 1% gel versus vehicle in the treatment of pseudofolliculitis barbae.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Facial Dermatoses; Folliculitis; Humans; Male; Middle Aged; New York; Pilot Projects; Treatment Outcome | 2004 |
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Nicotinic Acids; Retinoids; Risk Factors; Time Factors; Treatment Outcome; United States | 2004 |
[Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Double-Blind Method; Female; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2004 |
Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Decanoic Acids; Drug Combinations; Epidemiologic Methods; Erythromycin; Female; Humans; Male; Patient Compliance; Patient Satisfaction; Treatment Outcome; Zinc Acetate | 2006 |
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Emollients; Female; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States | 2006 |
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
Topics: Administration, Topical; Adult; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Disease Progression; Female; Fluticasone; Humans; Hydrogels; Hypopigmentation; Male; Treatment Outcome; Ultraviolet Therapy | 2006 |
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Decanoic Acids; Dermatologic Agents; Drug Combinations; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome; Zinc Acetate | 2007 |
Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Back; Benzoyl Peroxide; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Single-Blind Method; Thorax; Treatment Outcome | 2007 |
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythema; Female; Gels; Humans; Male; Naphthalenes; Pruritus; Skin; Time Factors; Treatment Outcome | 2007 |
Pilot investigation of the hydrating effects of topical acne medications.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Gels; Humans; Middle Aged; Nonprescription Drugs; Pilot Projects; Skin; Skin Physiological Phenomena; Sulfacetamide; Treatment Outcome; Water; Water Loss, Insensible; Wettability | 2007 |
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Male; Microspheres; Naphthalenes; Propionibacterium acnes; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Humans; Male; Naphthalenes; Propionibacterium; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2008 |
Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Treatment Outcome | 2008 |
Comparative irritation potential of two combination acne products: a randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers.
Topics: Acne Vulgaris; Administration, Topical; Analysis of Variance; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Humans; Male; Middle Aged; Patch Tests | 2008 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Treatment Outcome | 2008 |
Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Prospective Studies | 2009 |
Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male | 2009 |
Comparative efficacy and safety results of two topical combination acne regimens.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Keratolytic Agents; Male; Propionibacterium acnes; Prospective Studies; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin; Young Adult | 2009 |
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Gels; Humans; Permeability; Single-Blind Method; Skin Absorption; Skin Irritancy Tests | 2009 |
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Salicylic Acid; Solubility; Time Factors; Treatment Outcome; Young Adult | 2009 |
Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Biological Availability; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Single-Blind Method; Solubility; Time Factors; Treatment Outcome; Young Adult | 2009 |
Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Detergents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Severity of Illness Index; Treatment Outcome; Tretinoin; Young Adult | 2009 |
Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Excipients; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Prospective Studies; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Single-Blind Method; Tretinoin | 2010 |
The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Laser Therapy; Male; Quality of Life; Severity of Illness Index; Single-Blind Method; Young Adult | 2010 |
Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Gels; Humans; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2010 |
Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Keratolytic Agents; Male; Severity of Illness Index; Single-Blind Method; Tretinoin; Young Adult | 2010 |
Comparison of the clinical efficacy of NBUVB and NBUVB with benzoyl peroxide/clindamycin in progressive macular hypomelanosis.
Topics: Benzoyl Peroxide; Clindamycin; Humans; Photochemotherapy | 2011 |
Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Prospective Studies; Salicylic Acid; Single-Blind Method; Young Adult | 2012 |
Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Belize; Benzoyl Peroxide; Canada; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Treatment Outcome; United States; Young Adult | 2011 |
Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Hispanic or Latino; Humans; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin Pigmentation; Treatment Outcome; Young Adult | 2012 |
Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Inflammation; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin Pigmentation; Treatment Outcome; Young Adult | 2012 |
Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Quality of Life; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2012 |
Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Racial Groups; Severity of Illness Index; Skin Pigmentation; Treatment Outcome | 2012 |
A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Salicylates; Treatment Outcome; Tretinoin; Young Adult | 2012 |
Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Intention to Treat Analysis; Male; Naphthalenes; Patient Preference; Single-Blind Method; Water Loss, Insensible; Young Adult | 2012 |
The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Pain; Patient Preference; Pruritus; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2012 |
A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Diagnostic Self Evaluation; Double-Blind Method; Drug Combinations; Erythema; Female; Humans; Irritants; Keratolytic Agents; Linear Models; Male; Naphthalenes; Pruritus; Skin; Tretinoin; Water Loss, Insensible; Young Adult | 2012 |
Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Diagnostic Self Evaluation; Drug Combinations; Erythema; Ethnicity; Female; Gels; Humans; Keratolytic Agents; Male; Sex Characteristics; Skin; Treatment Outcome; Young Adult | 2012 |
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Chi-Square Distribution; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Face; Female; Gels; Humans; Male; Nicotinic Acids; Ointments; Quality of Life; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2013 |
Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Single-Blind Method; Skin Care; Sunscreening Agents; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Tretinoin; Young Adult | 2013 |
Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Severity of Illness Index; Treatment Outcome | 2013 |
A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Delayed-Action Preparations; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Inflammation; Male; Minocycline; Severity of Illness Index; Tablets; Treatment Outcome; Tretinoin; Young Adult | 2013 |
Tolerability and irritation potential of four topical acne regimens in healthy subjects.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dapsone; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Naphthalenes; Single-Blind Method | 2013 |
Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, acti
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Young Adult | 2015 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Child; Clindamycin; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Water; Young Adult | 2014 |
Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Benzoyl Peroxide; Case-Control Studies; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Quality of Life; Sebum; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
Topics: Acne Vulgaris; Administration, Topical; Adult; Age Factors; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Sex Factors; Treatment Outcome; Young Adult | 2015 |
Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer.
Topics: Acneiform Eruptions; Administration, Cutaneous; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Benzoyl Peroxide; Cetuximab; Clindamycin; Colorectal Neoplasms; Erythema; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Pruritus; Quality of Life | 2016 |
Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
Topics: Acne Vulgaris; Adolescent; Benzoyl Peroxide; Child; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Humans; Male; Single-Blind Method; Treatment Outcome; Tyrothricin; Young Adult | 2016 |
A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dicarboxylic Acids; Drug Therapy, Combination; Humans; Middle Aged; Single-Blind Method; Young Adult | 2016 |
A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; China; Clindamycin; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Young Adult | 2016 |
Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Area Under Curve; Asian People; Benzoic Acid; Benzoyl Peroxide; Biotransformation; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Hippurates; Humans; Japan; Male; Metabolic Clearance Rate; Young Adult | 2015 |
Benzoyl peroxide and clindamycin topical skin preparation decreases Propionibacterium acnes colonization in shoulder arthroscopy.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Bacterial Agents; Arthroscopy; Benzoyl Peroxide; Clindamycin; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Propionibacterium acnes; Prospective Studies; Shoulder Joint; Surgical Wound Infection; Treatment Outcome | 2017 |
Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Erythema; Female; Gels; Humans; Middle Aged; Patient Satisfaction; Treatment Outcome | 2017 |
Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, invest
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Combined Modality Therapy; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Japan; Male; Patient Preference; Quality of Life; Severity of Illness Index; Young Adult | 2018 |
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Male; Metal Nanoparticles; Patient Satisfaction; Quality of Life; Silver; Treatment Outcome; Young Adult | 2017 |
Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Face; Female; Gels; Humans; Hyperpigmentation; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Young Adult | 2022 |
The efficacy of topical preparations in reducing the incidence of Cutibacterium acnes at the start and conclusion of total shoulder arthroplasty: a randomized controlled trial.
Topics: Arthroplasty, Replacement, Shoulder; Benzoyl Peroxide; Clindamycin; Gram-Positive Bacterial Infections; Humans; Incidence; Peroxides; Propionibacterium acnes; Prospective Studies; Shoulder Joint; Skin; Triclosan | 2022 |
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Hidradenitis Suppurativa; Humans; Pain; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2023 |
47 other study(ies) available for benzoyl peroxide and clindamycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An update on acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Tretinoin | 1977 |
Treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Tetracyclines; Tretinoin | 1979 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Current topical acne therapy (continuing education).
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Humans; Patient Compliance; Sulfur | 1985 |
Topical antibiotics and topical antimicrobial agents in acne therapy.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Demeclocycline; Erythromycin; Fatty Acids, Nonesterified; Humans; Neomycin; Novobiocin; Peroxides; Propionibacterium acnes; Skin; Triglycerides | 1980 |
Acne: emphasis on adolescent acne and the role of antibiotics.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Erythromycin; Female; Humans; Male; Sulfamethoxazole; Sulfur; Tetracyclines; Tretinoin; Trimethoprim | 1980 |
Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Gels; Humans | 2001 |
The development of antibiotic resistance in Propionibacterium acnes.
Topics: Benzoyl Peroxide; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Propionibacterium acnes | 2001 |
Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Humans; Severity of Illness Index | 2001 |
Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Humans | 2001 |
Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Gels; Humans | 2001 |
The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Colony Count, Microbial; Data Interpretation, Statistical; Drug Combinations; Female; Forehead; Gels; Humans; Male; Middle Aged; Ointments; Propionibacterium acnes; Skin; Solutions; Time Factors | 2001 |
Clindoxyl gel for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans | 2002 |
Misleading readers in stating, "two studies indicate that results from open-label observational studies".
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Humans; Patient Satisfaction; Severity of Illness Index | 2003 |
Topical treatment for the inflamed lesion in acne, rosacea, and pseudofolliculitis barbae.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Facial Dermatoses; Folliculitis; Humans; Rosacea | 2004 |
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Clindamycin; Drug Combinations; Evaluation Studies as Topic; Female; Gels; Humans; Multicenter Studies as Topic; Patient Satisfaction; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Retinoids; Skin; Treatment Outcome | 2006 |
The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%.
Topics: Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Stability; Drug Therapy, Combination; Erythromycin; Gels; Humans; Keratolytic Agents; Microspheres; Models, Biological; Tretinoin; Ultraviolet Rays | 2006 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
The chemistry and synergy of benzoyl peroxide with clindamycin.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Synergism; Drug Therapy, Combination; Humans | 2008 |
The effect of vehicle formulation on acne medication tolerability.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dimethylpolysiloxanes; Female; Glycerol; Humans; Pharmaceutical Vehicles; Tretinoin; Young Adult | 2008 |
Taking the stress out of acne management.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Follow-Up Studies; Humans; Isotretinoin; Male; Young Adult | 2009 |
New drug information. Acanya.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Gels; Humans; Keratolytic Agents | 2009 |
Photocarcinogenesis and toxicity of benzoyl peroxide in hairless mice after simulated solar radiation.
Topics: Animals; Benzoyl Peroxide; Carcinogenicity Tests; Carcinoma, Squamous Cell; Clindamycin; Erythema; Female; Kaplan-Meier Estimate; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Pulmonary Edema; Skin; Skin Neoplasms; Skin Pigmentation; Ultraviolet Rays | 2010 |
The use of a clindamycin 1%-benzoyl peroxide 5% topical gel in the treatment of pitted keratolysis: a novel therapy.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Foot Dermatoses; Gels; Gram-Positive Bacterial Infections; Humans; Hyperhidrosis; Male; Prognosis; Prospective Studies | 2009 |
Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans | 2009 |
Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Synergism; Gels; Humans; Medication Adherence; Time Factors | 2009 |
Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Excipients; Gels; Humans; Medication Adherence; Retinoids; Treatment Outcome | 2009 |
Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Synergism; Excipients; Gels; Humans | 2009 |
[Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
Topics: Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypopigmentation; Remission Induction; Young Adult | 2010 |
Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
Topics: Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Humans; Hypopigmentation; Laser Therapy | 2011 |
How patients experience and manage dryness and irritation from acne treatment.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Data Collection; Dermatologic Agents; Drug Combinations; Female; Humans; Internet; Male; Medication Adherence; Severity of Illness Index; Young Adult | 2011 |
Treatment of severe acne with low-dose isotretinoin.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Female; Humans; Isotretinoin; Male; Naphthalenes; Photography; Retrospective Studies; Severity of Illness Index | 2012 |
Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for th
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Ceramides; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Treatment Outcome; Tretinoin; Young Adult | 2012 |
Lower extremities and iliopsoas pyomyositis with concurrent septic arthritis and spinal epidural abscess in a diabetic patient.
Topics: Arthritis, Infectious; Benzoyl Peroxide; Ciprofloxacin; Clindamycin; Drug Combinations; Epidural Abscess; Humans; Magnetic Resonance Imaging; Male; Pyomyositis; Staphylococcal Infections; Thigh; Vancomycin | 2013 |
Acneiform eruption due to vitamin B12: a problem still unsolved.
Topics: Acneiform Eruptions; Adapalene; Adult; Benzoyl Peroxide; Brain Damage, Chronic; Brain Injuries; Clindamycin; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Lymecycline; Male; Naphthalenes; Vitamin B 12 | 2014 |
Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Topics: Acneiform Eruptions; Administration, Topical; Adult; Antibodies, Monoclonal, Humanized; Benzoyl Peroxide; Breast Neoplasms; Carcinoma, Ductal, Breast; Clindamycin; Drug Eruptions; Female; Humans; Middle Aged; Minocycline; Receptor, ErbB-2; Trastuzumab | 2015 |
Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC(®) ) in the treatment of EGFR inhibitors-associated acneiform eruption.
Topics: Acneiform Eruptions; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; ErbB Receptors; Gels; Humans; Male | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Prescriptions; Drug Resistance; Drug Therapy, Combination; Drug Utilization; Erythromycin; Female; Health Care Surveys; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Retinoids; Retrospective Studies; United States; Young Adult | 2017 |
Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; alpha-Tocopherol; Anti-Infective Agents; Ascorbic Acid; Atrophy; Benzoyl Peroxide; Chemexfoliation; Cicatrix; Clindamycin; Combined Modality Therapy; Erythema; Female; Glycolates; Humans; Hyperpigmentation; Iontophoresis; Japan; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Measuring acne using Coproporphyrin III, Protoporphyrin IX, and lesion-specific inflammation: an exploratory study.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Coproporphyrins; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Optical Imaging; Porphyrins; Propionibacterium acnes; Protoporphyrins; Severity of Illness Index; Tyrothricin; Young Adult | 2017 |
Erythema-directed digital photography for the enhanced evaluation of topical treatments for acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Female; Humans; Male; Photography; Treatment Outcome; Tretinoin; Young Adult | 2018 |
Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide.
Topics: Administration, Cutaneous; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Back; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Male; Propionibacterium acnes; Random Allocation; Skin | 2019 |
Tretinoin/benzoyl peroxide cream (Twyneo) for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans; Tretinoin | 2022 |
In Total Shoulder Arthroplasty, Preoperative Washes with Benzyl Peroxide, with or without Clindamycin, Reduced Skin Cutibacterium acnes Colonization Compared with pHisoHex Before Skin Preparation and Draping but Not During Surgery.
Topics: Arthroplasty, Replacement, Shoulder; Benzoyl Peroxide; Clindamycin; Gram-Positive Bacterial Infections; Humans; Peroxides; Propionibacterium acnes; Shoulder; Shoulder Joint; Skin; Triclosan | 2023 |
Effects of mesotherapy introduction of compound glycyrrhizin injection on the treatment of moderate to severe acne.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Glycyrrhizic Acid; Humans; Mesotherapy; Treatment Outcome | 2023 |